|
|
Previous Article | Table of Contents | Next Article 
Active Site Inhibited Factor VIIa (DEGR VIIa) Attenuates the
Coagulant and Interleukin-6 and -8, but not Tumor Necrosis Factor,
Responses of the Baboon to LD100 Escherichia
coli
F.B. Taylor Jr,
A.C.K. Chang,
G. Peer,
A. Li,
M. Ezban, and
U. Hedner
From the Oklahoma Medical Research Foundation, Oklahoma City; the
University of Oklahoma Health Sciences Center, Oklahoma City; and Novo
Nordisk, Gentofte, Denmark.
Antitissue factor antibody attenuated the coagulopathic and lethal
responses to LD100 Escherichia coli, whereas active
site inhibited factor Xa inhibited only the coagulopathic response. In
this study, we wished to determine: (1) whether active site inhibited
factor VIIa blocks the coagulopathic and/or attenuates the
lethal effects of LD100 E coli and (2) whether
these effects are accompanied by attenuation of the inflammatory
cytokine response to LD100 E coli. Eight baboons
infused for 2 hours with LD100 E coli also were
given five bolus infusions of DEGR VIIa of 280 µg/kg at
T = 10 minutes, +2, 4, 6, and 8 hours and observed for changes in
vital signs, and the concentrations of hemostatic components (fibrinogen, platelets, fibrin degradation products) and inflammatory mediators (tumor necrosis factor [TNF], interleukin-6 [IL-6], IL-8)
at T = 0, 1, 2, 4, 6, and 8 hours. Eight control baboons were also
infused with LD100 E coli alone and followed as
described above. Four of the eight baboons treated with DEGR VIIa were
permanent 7-day survivors versus none in the control group. The mean
survival times for the treated and control groups were 116 ± 22 and
26 ± 8 hours, respectively. These values differed significantly from each other, (P = .0008). The decrease in platelet and
fibrinogen concentrations and the increase in fibrin degradation
products observed in the control group were significantly attenuated in the treated group, as was thrombosis of renal glomerular capillaries. Treatment with DEGR VIIa showed no effect on the peak TNF response to
LD100 E coli at T = 2 hours (170 ± 32 v
120 ± 35 ng/mL). DEGR VIIa, however, did attenuate the IL-6 and IL-8
responses at T = 8 hours (ie, the IL-6 concentrations were 81 ± 10 for treated and 1,256 ± 236 for the control groups and the IL-8
concentrations were 28 ± 3.9 for the treated and 60 ± 8.2 for the
control group). These values for IL-6 and IL-8 differed significantly
from each other between the treated and control groups (P = .0001 and .0074, respectively). It should be noted that the initial
responses of IL-6 and IL-8 up to T = 4 hours were not attenuated. We
concluded that DEGR VIIa treatment attenuates inflammatory, as well as
hemostatic system responses to LD100 E coli. We
hypothesize that this occurs through interference with the assembly
and/or interactions of tissue factor/VIIa complexes.
Blood, Vol. 91 No. 5 (March 1), 1998:
pp. 1609-1615
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Kinev and R. Roubey
Tissue factor in the antiphospholipid syndrome
Lupus,
October 1, 2008;
17(10):
953 - 959.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. I. Pahlman, E. Malmstrom, M. Morgelin, and H. Herwald
M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes
Microbiology,
August 1, 2007;
153(8):
2458 - 2464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ahamed, F. Niessen, T. Kurokawa, Y. K. Lee, G. Bhattacharjee, J. H. Morrissey, and W. Ruf
Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia
Blood,
June 15, 2007;
109(12):
5251 - 5259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Stearns-Kurosawa, F. Lupu, F. B. Taylor Jr., G. Kinasewitz, and S. Kurosawa
Sepsis and Pathophysiology of Anthrax in a Nonhuman Primate Model
Am. J. Pathol.,
August 1, 2006;
169(2):
433 - 444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jaggers and J. H. Lawson
Coagulopathy and Inflammation in Neonatal Heart Surgery: Mechanisms and Strategies
Ann. Thorac. Surg.,
June 1, 2006;
81(6):
S2360 - S2366.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Camerer, I. Cornelissen, H. Kataoka, D. N. Duong, Y.-W. Zheng, and S. R. Coughlin
Roles of protease-activated receptors in a mouse model of endotoxemia
Blood,
May 15, 2006;
107(10):
3912 - 3921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zeerleder, C. E. Hack, and W. A. Wuillemin
Disseminated Intravascular Coagulation in Sepsis
Chest,
October 1, 2005;
128(4):
2864 - 2875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. V. M. Rao and U. R. Pendurthi
Tissue Factor-Factor VIIa Signaling
Arterioscler Thromb Vasc Biol,
January 1, 2005;
25(1):
47 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Schabbauer, M. Tencati, B. Pedersen, R. Pawlinski, and N. Mackman
PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice
Arterioscler Thromb Vasc Biol,
October 1, 2004;
24(10):
1963 - 1969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sharma, E. Melis, M. J. Hickey, C. D. Clyne, J. Erlich, L. M. Khachigian, P. Davenport, E. Morand, P. Carmeliet, and P. G. Tipping
The Cytoplasmic Domain of Tissue Factor Contributes to Leukocyte Recruitment and Death in Endotoxemia
Am. J. Pathol.,
July 1, 2004;
165(1):
331 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mackman
Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development
Arterioscler Thromb Vasc Biol,
June 1, 2004;
24(6):
1015 - 1022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Versteeg, C. A. Spek, S. H. Slofstra, S. H. Diks, D. J. Richel, and M. P. Peppelenbosch
FVIIa:TF Induces Cell Survival via G12/G13-Dependent Jak/STAT Activation and BclXL Production
Circ. Res.,
April 30, 2004;
94(8):
1032 - 1040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pawlinski, B. Pedersen, G. Schabbauer, M. Tencati, T. Holscher, W. Boisvert, P. Andrade-Gordon, R. D. Frank, and N. Mackman
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia
Blood,
February 15, 2004;
103(4):
1342 - 1347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dorfleutner and W. Ruf
Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation
Blood,
December 1, 2003;
102(12):
3998 - 4005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riewald, R. J. Petrovan, A. Donner, and W. Ruf
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells
Innate Immunity,
October 1, 2003;
9(5):
317 - 321.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Carraway, K. E. Welty-Wolf, D. L. Miller, T. L. Ortel, S. Idell, A. J. Ghio, L. C. Petersen, and C. A. Piantadosi
Blockade of Tissue Factor: Treatment for Organ Injury in Established Sepsis
Am. J. Respir. Crit. Care Med.,
May 1, 2003;
167(9):
1200 - 1209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Versteeg, B. B. Sorensen, S. H. Slofstra, J. H. M. Van den Brande, J. C. Stam, P. M. P. van Bergen en Henegouwen, D. J. Richel, L. C. Petersen, and M. P. Peppelenbosch
VIIa/Tissue Factor Interaction Results in a Tissue Factor Cytoplasmic Domain-independent Activation of Protein Synthesis, p70, and p90 S6 Kinase Phosphorylation
J. Biol. Chem.,
July 19, 2002;
277(30):
27065 - 27072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Miller, K. Welty-Wolf, M. S. Carraway, M. Ezban, A. Ghio, H. Suliman, and C. A. Piantadosi
Extrinsic Coagulation Blockade Attenuates Lung Injury and Proinflammatory Cytokine Release after Intratracheal Lipopolysaccharide
Am. J. Respir. Cell Mol. Biol.,
June 1, 2002;
26(6):
650 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Camerer, H. Kataoka, M. Kahn, K. Lease, and S. R. Coughlin
Genetic Evidence That Protease-activated Receptors Mediate Factor Xa Signaling in Endothelial Cells
J. Biol. Chem.,
May 3, 2002;
277(18):
16081 - 16087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iakhiaev, U. R. Pendurthi, and L. V. M. Rao
Active Site Blockade of Factor VIIa Alters Its Intracellular Distribution
J. Biol. Chem.,
November 30, 2001;
276(49):
45895 - 45901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. WELTY-WOLF, M. S. CARRAWAY, D. L. MILLER, T. L. ORTEL, M. EZBAN, A. J. GHIO, S. IDELL, and C. A. PIANTADOSI
Coagulation Blockade Prevents Sepsis-induced Respiratory and Renal Failure in Baboons
Am. J. Respir. Crit. Care Med.,
November 15, 2001;
164(10):
1988 - 1996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. van der Poll
Coagulation and inflammation
Innate Immunity,
August 1, 2001;
7(4):
301 - 304.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riewald and W. Ruf
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor
PNAS,
July 3, 2001;
98(14):
7742 - 7747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riewald, V. V. Kravchenko, R. J. Petrovan, P. J. O'Brien, L. F. Brass, R. J. Ulevitch, and W. Ruf
Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1
Blood,
May 15, 2001;
97(10):
3109 - 3116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Franco, E. de Jonge, P. E. P. Dekkers, J. J. Timmerman, C. A. Spek, S. J. H. van Deventer, P. van Deursen, L. van Kerkhoff, B. van Gemen, H. ten Cate, et al.
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation
Blood,
July 15, 2000;
96(2):
554 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. B. Taylor Jr, D. J. Stearns-Kurosawa, S. Kurosawa, G. Ferrell, A. C. K. Chang, Z. Laszik, S. Kosanke, G. Peer, and C. T. Esmon
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis
Blood,
March 1, 2000;
95(5):
1680 - 1686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Camerer, E. Gjernes, M. Wiiger, S. Pringle, and H. Prydz
Binding of Factor VIIa to Tissue Factor on Keratinocytes Induces Gene Expression
J. Biol. Chem.,
February 25, 2000;
275(9):
6580 - 6585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. de Jonge, P. E. P. Dekkers, A. A. Creasey, C. E. Hack, S. K. Paulson, A. Karim, J. Kesecioglu, M. Levi, S. J. H. van Deventer, and T. van der Poll
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
Blood,
February 15, 2000;
95(4):
1124 - 1129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. B. Taylor Jr., V. L. Tesh, L. DeBault, A. Li, A. C. K. Chang, S. D. Kosanke, T. J. Pysher, and R. L. Siegler
Characterization of the Baboon Responses to Shiga-Like Toxin : Descriptive Study of a New Primate Model of Toxic Responses to Stx-1
Am. J. Pathol.,
April 1, 1999;
154(4):
1285 - 1299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Versteeg, I. Hoedemaeker, S. H. Diks, J. C. Stam, M. Spaargaren, P. M. P. van Bergen en Henegouwen, S. J. H. van Deventer, and M. P. Peppelenbosch
Factor VIIa/Tissue Factor-induced Signaling via Activation of Src-like Kinases, Phosphatidylinositol 3-Kinase, and Rac
J. Biol. Chem.,
September 8, 2000;
275(37):
28750 - 28756.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|